Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take Nintedanib
A Spain-based BALANCE trial is evaluating whether a patient support program improves outcomes for people with pulmonary fibrosis who are tre…
-
EMA approval · 2026-01-06EMA Authorised: Ofev (nintedanib) — Boehringer Ingelheim International GmbH
The European Medicines Agency authorised a label expansion for Ofev (nintedanib) to cover additional interstitial lung diseases, including s…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Routine vs On-demand ECMO for Lung Transplantation [NA]
A clinical trial update indicates a study comparing routine versus on-demand ECMO support for lung transplantation is currently recruiting a…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Implementation of Home Monitoring in Patients With Pulmonary Fibrosis [NA]
Recruitment is ongoing for a clinical study evaluating home monitoring in patients with pulmonary fibrosis and interstitial lung disease.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Genetics of the Combined Pulmonary Fibrosis and Emphysema Syndrome [NA]
This update reports the completion of a genetics study on Combined Pulmonary Fibrosis and Emphysema Syndrome. The study appears to have incl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis [Phase 2, Phase 3]
This document reports an ongoing Phase 2/Phase 3 clinical trial evaluating sirolimus for preventing post-COVID fibrosis in patients with COV…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of 9MW3811 in Healthy Subjects [Phase 1]
Phase 1 study evaluating safety, tolerability and pharmacokinetics of the investigational drug 9MW3811 in healthy subjects has completed. It…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: AI Assisted Detection of Chest X-Rays
A completed clinical trial evaluated an AI-assisted chest X-ray detection system. The study covered various thoracic conditions including pu…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies [Phase 2]
Phase 2 pilot study evaluating pirfenidone in pulmonary fibrosis with anti-myeloperoxidase antibodies has completed. The update notes the tr…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Impact of Airway Mucus Plugs on Secondary Pulmonary Fibrosis in COPD Patients: A Single-Center Case-Control Study
A single-center case-control study to assess whether airway mucus plugs contribute to secondary pulmonary fibrosis in COPD patients; the tri…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects [Phase 1]
Phase 1 trial evaluating potential drug interactions among HRS-9813, pirfenidone, and nintedanib in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Frequency-time Analysis of Pathological Lung Sounds: Detection and Quantification of Pathological Sounds in Patients With Cystic Fibrosis, Pulmonary Fibrosis or COPD (Chronic Obstructive Pulmonary Disease)
A clinical trial examining frequency-time analysis of pathological lung sounds in patients with cystic fibrosis, pulmonary fibrosis, or chro…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Genentech Validation Tool for Pulmonary Fibrosis
A clinical trial update indicates a Genentech validation tool for pulmonary fibrosis is being evaluated for interstitial lung disease, with …
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study
The RESPIFLU study (NCT01271842) reports long-term outcomes and lung capacity in survivors of acute respiratory distress syndrome due to inf…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Automated Oxygen Titration During Walking in Patients With Lung Fibrosis (OXYWILD) [NA]
This entry notes the completed clinical trial OXYWILD evaluating automated oxygen titration during walking in patients with pulmonary fibros…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Interstitial Lung Disease Research Unit Biobank
A clinical trial update for an Interstitial Lung Disease Research Unit Biobank at University of Kansas Medical Center; the study is currentl…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Clinical Study of Allogeneic Fat Decellularized Active Protein in the Treatment of Pulmonary Fibrosis [EARLY_Phase 1]
An early Phase 1 clinical study of allogeneic fat decellularized active protein for pulmonary fibrosis is listed as active but not recruitin…
-
EMA approval · 2025-09-05EMA Authorised: Nintedanib Viatris (nintedanib) — Viatris Limited
The European Medicines Agency authorised a generic version of nintedanib (Nintedanib Viatris) for idiopathic pulmonary fibrosis and related …
-
EMA approval · 2025-08-29EMA Authorised: Nintedanib Accord (nintedanib) — Accord Healthcare S.L.U.
The EMA authorised Nintedanib Accord for indications including Idiopathic Pulmonary Fibrosis, interstitial lung diseases, systemic sclerosis…
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis [Phase 2]
The Phase 2 TELO-SCOPE study evaluating danazol to attenuate telomere attrition in pulmonary fibrosis has been terminated.
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Pulmonary Outcomes on Patients With Lung Fibrosis [NA]
This Clinical Trial Update reports on a study examining pulmonary outcomes in patients with pulmonary fibrosis, and notes that the trial is …
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Physical Exercise Program for Adults With Diffuse Interstitial Lung Disease in a Pulmonary Rehabilitation Context [NA]
This ClinicalTrials.gov entry reports that an exercise program for adults with diffuse interstitial lung disease within a pulmonary rehabili…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: A Trial of HRS-9813 Capsule and Tablet in Healthy Subjects [Phase 1]
Phase 1 trial update reports completion of a study evaluating HRS-9813 capsules and tablets in healthy subjects, with pulmonary fibrosis ref…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: FAPI PET for Lung Fibrosis [EARLY_Phase 1]
An early-phase Phase 1 trial evaluating FAPI PET imaging for interstitial lung disease and pulmonary fibrosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: The Effectiveness of Pulmonary Rehabilitation on Saturation in Patients With Idiopathic Pulmonary Fibrosis [NA]
A completed clinical trial assessing the effectiveness of pulmonary rehabilitation on oxygen saturation in patients with idiopathic pulmonar…